A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors
Clinical trial NCT05159700 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05159700
- Sponsor
- Zhuhai Yufan Biotechnologies Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2024-07-17
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.